Normal and abnormal biology of the beta-amyloid precursor protein.
暂无分享,去创建一个
[1] T. Mandybur. The incidence of cerebral amyloid angiopathy in Alzheimer's disease , 1975, Neurology.
[2] D. Munoz. Chromogranin A-like immunoreactive neurites are major constituents of senile plaques. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[3] W. Griffin,et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Hardy,et al. A locus for familial early–onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the α1–antichymotrypsin gene , 1992, Nature Genetics.
[5] M J Ball,et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. , 1993, The Journal of biological chemistry.
[6] S. Shiojiri,et al. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity , 1988, Nature.
[7] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[8] B. Hyman,et al. Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid β protein precursor , 1993, Nature Genetics.
[9] L. Thal,et al. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide , 1993, Nature.
[10] F. Tagliavini,et al. Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals , 1988, Neuroscience Letters.
[11] R. Senior,et al. The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1 antitrypsin-elastase complexes and amyloid-beta peptide. , 1992, The Journal of clinical investigation.
[12] R. Neve,et al. The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. , 1990, The Journal of biological chemistry.
[13] H. Braak,et al. Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: A third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques , 1986, Neuroscience Letters.
[14] D. Selkoe. Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease , 1989, Neurobiology of Aging.
[15] Carl W. Cotman,et al. Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor , 1989, Nature.
[16] D. Stephenson,et al. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat , 1992, Brain Research.
[17] C. Broeckhoven,et al. Mapping of a gene predisposing to early–onset Alzheimer's disease to chromosome 14q24.3 , 1992, Nature Genetics.
[18] C. Cotman,et al. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.
[19] H. Vinters,et al. Immunohistochemical study of cerebral amyloid angiopathy: use of an antiserum to a synthetic 28-amino-acid peptide fragment of the Alzheimer's disease amyloid precursor. , 1988, Human pathology.
[20] C. Masters,et al. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.
[21] D. Selkoe,et al. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. , 1992, The Journal of biological chemistry.
[22] P. Cras,et al. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Eikelenboom,et al. Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease , 1990, Neuroscience Letters.
[24] S. Younkin,et al. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.
[25] B. Yankner,et al. An antibody to β amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types , 1991, Neuroscience Letters.
[26] J. Growdon,et al. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. , 1992, Science.
[27] D. Selkoe,et al. Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.
[28] P. S. St George-Hyslop,et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.
[29] G. Broze,et al. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. , 1990, Science.
[30] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[31] R. Kalaria,et al. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders , 1991, Neuropathology and applied neurobiology.
[32] M. Kidd. Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease , 1963, Nature.
[33] B. Greenberg,et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors , 1988, Nature.
[34] S. Hirai,et al. Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain. , 1989, The American journal of pathology.
[35] F. D. de Sauvage,et al. A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. , 1989, Science.
[36] J. Weber,et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. , 1992, Science.
[37] P. Greengard,et al. Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Wegiel,et al. Ultrastructural Studies of the Cells Forming Amyloid Fibers in Classical Plaques , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[39] K. Davis,et al. Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age. , 1987, Archives of general psychiatry.
[40] I. Nishimoto,et al. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go , 1993, Nature.
[41] C. Cotman,et al. β-Amyloid protein promotes neuritic branching in hippocampal cultures , 1990, Neuroscience Letters.
[42] F. Tagliavini,et al. Alzheimer patients and Down patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques , 1989, Neuroscience Letters.
[43] R. Tanzi,et al. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[44] W. Engel,et al. Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis. , 1992, The American journal of pathology.
[45] D. Selkoe,et al. Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging , 1988, Brain Research.
[46] J. Trojanowski,et al. The disordered neuronal cytoskeleton in Alzheimer's disease , 1992, Current Opinion in Neurobiology.
[47] P. Cras,et al. Serial reconstruction of β-protein amyloid plaques: relationship to microvessels and size distribution , 1992, Brain Research.
[48] I. Lieberburg,et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.